De novo malignancy emerges as a major cause of mor...[Transplant Proc. 1993]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

1: Transplant Proc. 1993 Feb;25(1 Pt 2):1383-4.Links

De novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation.

Australia and New Zealand Combined Dialysis and Transplant Registry, Queen Elizabeth Hospital, South Australia.

PMID: 8442150 [PubMed - indexed for MEDLINE]

Patient Drug Information

Prednisone (Prednisone Intensol®, Sterapred®, Sterapred® DS) Prednisone is used alone or with other medications to treat the symptoms of low corticosteroid levels (lack of certain substances that are usually produced by the body and are needed for normal body functioning). Prednis...

» read more ...
Mercaptopurine (Purinethol®) Your doctor has ordered the drug mercaptopurine to help treat your illness. The drug is taken by mouth in tablet form.

» read more ...
Azathioprine (Azasan®, Imuran®) Azathioprine is used with other medications to prevent rejection of kidney transplants. It is also used to treat severe rheumatoid arthritis (a condition in which the body attacks its own joints, causing pain and swellin...

» read more ...

Display Show